Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia
Antineoplastic Combined Chemotherapy Protocols
Leukemia, Myeloid, Acute
Induction treatment with A + C did not improve the CR rate compared with D + C in patients with sAML.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency